Phase II clinical trial of bortezomib and bevacizumab combination in recurrent glioblastoma.

被引:0
|
作者
Bota, D. A.
Eroglu, Z.
Reardon, D. A.
Fu, B. D.
Norfleet, J.
Desjardins, A.
Linskey, M. E.
Peters, K.
Friedman, H. S.
Vredenburgh, J. J.
机构
[1] Univ Calif Irvine, Med Ctr, Orange, CA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Univ Calif Irvine, Orange, CA 92668 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2056
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
    Ghiaseddin, Ashley
    Reardon, David A.
    Massey, Woody
    Mannerino, Alexandra
    Lipp, Eric S.
    Herndon, James E.
    McSherry, Frances
    Desjardins, Annick
    Randazzo, Dina M.
    Vlahovic, Gordana
    Friedman, Henry S.
    Peters, Katherine B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Phase II trial of dovitinib in recurrent glioblastoma.
    Ahluwalia, Manmeet Singh
    Papadantonakis, Nikolaos
    Venur, Vyshak Alva
    Schilero, Cathy
    Peereboom, David M.
    Stevens, Glen
    Rosenfeld, Steven
    Vogelbaum, Michael A.
    Elson, Paul
    Nixon, Andrew B.
    McCrae, Keith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial.
    Fallah, Jaleh
    Chaudhary, Rekha T.
    Rogers, Lisa R.
    Wei, Wei
    Brewer, Cathy J.
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I/II clinical trial data
    Bota, Daniela A.
    Mason, Warren
    Kesari, Santosh
    Magge, Rajiv
    Winograd, Benjamin
    Elias, Ileana
    Reich, Steven D.
    Levin, Nancy
    Trikha, Mohit
    Desjardins, Annick
    [J]. NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [5] Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
    Lee, Eudocia Quant
    Muzikansky, Alona
    Reardon, David A.
    Dietrich, Jorg
    Nayak, Lakshmi
    Duda, Dan G.
    Chukwueke, Ugonma Nnenna
    Beroukhim, Rameen
    Doherty, Lisa M.
    Kane, Caroline
    LaFrankie, Debra C.
    Fontana, Brittney
    Stefanik, Jennifer
    Ruland, Sandra
    Caruso, Victoria
    Bruno, Jennifer
    Gaffey, Sarah C.
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] GLIAVAX: A stratified phase II clinical trial of avelumab and axitinib in patients with recurrent glioblastoma.
    Neyns, Bart
    Ben Salama, Laila
    Awada, Gil
    De Cremer, Jennifer
    Schwarze, Julia Katharina
    Seynaeve, Laura
    Du Four, Stephanie
    Fischbuch, Lydia
    Vanbinst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Rogiers, Anne
    Theuns, Peter
    Duerinck, Johnny
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] A PHASE II TRIAL OF INVESTIGATIONAL AGENT TANDUTINIB IN COMBINATION WITH BEVACIZUMAB FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
    Sul, Joohee
    Odia, Yazmin
    Zhang, Weiting
    Shih, Joanna
    Butman, John A.
    Hammoud, Dina
    Kreisl, Teri N.
    Iwamoto, Fabio
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 73 - 73
  • [8] PHASE II STUDY OF PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
    Lee, Eudocia
    Reardon, David
    Schiff, David
    Drappatz, Jan
    Muzikansky, Alona
    Hammond, Samantha
    Grimm, Sean
    Norden, Andrew
    Beroukhim, Rameen
    McCluskey, Christine
    Chi, Andrew
    Batchelor, Tracy
    Smith, Katrina
    Gaffey, Sarah
    Gerard, Mary
    Snodgras, Susan
    Raizer, Jeffrey
    Wen, Patrick
    [J]. NEURO-ONCOLOGY, 2013, 15 : 118 - 118
  • [9] NCCTG PHASE II TRIAL OF BEVACIZUMAB IN COMBINATION WITH SORAFENIB (BEV/SOR) IN RECURRENT GLIOBLASTOMA (rGBM)
    Galanis, Evanthia
    Anderson, S. Keith
    Lafky, Jacqueline M.
    Kaufmann, Timothy J.
    Uhm, Joon H.
    Giannini, Caterina
    Kumar, Shaji K.
    Northfelt, Donald W.
    Flynn, Patrick J.
    Jaeckle, Kurt A.
    Buckner, Jan C.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 62 - 62
  • [10] A phase I trial of vorinostat in combination with bevacizumab and irinotecan in recurrent glioblastoma
    Chinnaiyan, P.
    Chowdhary, S.
    Brem, S.
    Yu, M.
    Murtagh, R.
    Rojiani, A.
    Tsai, Y.
    Pan, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)